Celontin is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Farmea. The primary component is Methsuximide.
Product ID | 24822-525_abac6b2e-bcd8-29c2-e053-2a95a90a2239 |
NDC | 24822-525 |
Product Type | Human Prescription Drug |
Proprietary Name | Celontin |
Generic Name | Methsuximide |
Dosage Form | Capsule |
Route of Administration | ORAL |
Marketing Start Date | 1999-01-01 |
Marketing Category | NDA / |
Application Number | NDA010596 |
Labeler Name | Farmea |
Substance Name | METHSUXIMIDE |
Active Ingredient Strength | 300 mg/1 |
Pharm Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
NDC | Brand Name | Generic Name |
---|---|---|
0071-0525 | Celontin | methsuximide |
24822-525 | Celontin | METHSUXIMIDE |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
CELONTIN 72011399 0642512 Live/Registered |
PARKE, DAVIS & COMPANY 1956-07-02 |